GENE ONLINE|News &
Opinion
Blog

NSCLC
Trials & Approvals Liquid Biopsy
FDA Approves Foundation Medicine’s Liquid Biopsy Test as Companion Diagnostic for Novartis’ Tabrecta
2021-07-18
Trials & Approvals NSCLC
FoundationOne CDx Okayed as Companion Diagnostic for Takeda’s Lung Cancer Drug
2021-07-04
Trials & Approvals PD-1 Inhibitor
Innovent, Lilly Bag Third Approval for PD-1 Inhibitor Tyvyt in China
2021-06-07
Trials & Approvals KRAS
We Have a Winner! Amgen Grabs First FDA Nod in the Race for Undruggable KRAS
2021-05-30
Trials & Approvals EGFR
FDA Approves First Targeted Therapy for EGFR Lung Cancer with Exon 20 Mutations
2021-05-24
Technology
How Liquid Biopsies are Helping in Detection of Cancer Relapse?
2021-04-17
Trials & Approvals PD-1 Inhibitor
Libtayo’s Second Approval in One Month Sets Up Lung Cancer Duel with Merck’s Keytruda
2021-02-24
Trials & Approvals Cancer
FDA Approval of Tepotinib Sets Stage for Merck Versus Novartis Showdown in Metastatic NSCLC Space
2021-02-05
Trials & Approvals NSCLC
Jounce Discontinues Phase 2 NSCLC Trial After its Combo Therapy with Ipilimubab Folds
2020-11-06
R&D PD-L1
With their Respective Immunotherapy Drugs, Arcus, AstraZeneca Combine to Combat Lung Cancer
2020-11-01
Technology Liquid Biopsy
FMI’s Liquid Biopsy Test Adds 3 Companion Diagnostic Indications for Advanced Ovarian, Breast and Lung Cancers
2020-10-30
R&D KRAS G12C Inhibitor
Mirati’s Successful Targeting of the “Undruggable” Shapes Up Regulatory Showdown with Amgen
2020-10-28
Trials & Approvals KRAS G12C Inhibitor
Amgen’s KRAS G12C Inhibitor Impresses in Phase 2 NSCLC Trial
2020-10-09
R&D
Amgen’s KRAS Inhibitor Registers Long-Lasting Performance in Solid Tumors
2020-09-27
R&D Cancer
3SBio Partnering with Samsung Bioepis Co-developing Bevacizumab Biosimilar for NSCLC
2020-09-16
1 2 3 4
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top